Financial reviews and presentations

Orion will publish Financial Statement Release for January-December 2020 on Tuesday, 9 February 2021 approximately at 12.00 noon EET. The release and related presentation material as well as link to live webcast and conference call info will be available here.

Read more

AGM 2021

The 2021 Annual General Meeting of Orion Corporation is planned to be held on 25 March 2021 in Helsinki.

Read more

FAQ

Orion Investor Relations have received several questions related to the coronavirus (COVID-19) pandemia and its impacts on Orion. We have listed here answers to some frequently asked questions.

Read more

Annual Reports

Orion Group's Financial Statement documents for 2019 are available here.

Read more

Corporate Governance Statement

The latest Corporate Governance Statement of Orion Corporation is available at the archive of Corporate Governance Statements.

Read more

Capital Markets Day 2019

Orion's Capital Markets Day was held on Wednesday 22 May 2019.

Read more

Stock Exchange Releases

1/12/2021 Recommendation by the Nomination Committee concerning the Board of Directors to be elected by the 2021 AGM of Orion Corporation
12/18/2020 8,242 Orion Corporation A shares converted into B shares
10/29/2020 Prosecutor pressed charges against a member of Orion’s Board of Directors for a suspected securities market offence – the suspected offence is not related to Orion
10/21/2020 Composition of the Nomination Committee of Orion Corporation

Press Releases

1/20/2021 Orion publishes Financial Statement Release for 2020 on Tuesday 9 February 2021
1/18/2021 Orion Animal Health and Vetoquinol expand collaboration – Vetoquinol to distribute Orion’s Clevor® in the USA and Orion to distribute Drontal® and Profender® products in Finland, Hungary and Romania
11/10/2020 Orion invests EUR 17 million in its production plants in Turku
11/4/2020 Orion Research Foundation grants 1 014 400 euros for research in 2021

Share information

Information about the price development of Orion's A and B shares. Also available a list of analysts covering Orion and the latest consensus estimate.

Read more

Major shareholders by votes

Monthly updated list of Orion's major shareholders by votes.

Read more

Orion's R&D Pipeline

Read more
Research 

Orion Executive Management Board

The members of the Board of Directors

Orion included in FTSE4Good Index

Orion Corporation has been included in the globally recognised FTSE4Good Index.

Read more

Our approach to corporate responsibility

Orion aims to grow faster than the pharmaceutical market

Research and development are Orion's strengths, and the company will continue to invest in them. The target is to increase net sales 1.5-fold by 2025.

Read more

Investing benefits both investors and society

Responsibility is one incentive when retail investors seek investments. Pharmaceuticals and healthcare is one of the most interesting sectors.

Read more
Orion's century
About Orion
Products and Services
Investors
FAQ
Media
Corporate Governance
AGM
Contact us